Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy (CT) in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumours (NSGCT): Final results of phase II trial

Annals of Oncology ◽

10.1093/annonc/mdz249.078 ◽

2019 ◽

Vol 30 ◽

pp. v398-v399

Author(s):

Tryakin ◽

M. Fedyanin ◽

Y. Segeev ◽

A. Bulanov ◽

V.B. Matveev ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours

Download Full-text

Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)

Annals of Oncology ◽

10.1093/annonc/mdy283.124 ◽

2018 ◽

Vol 29 ◽

pp. viii325

Author(s):

R.A. Huddart ◽

F. Cafferty ◽

J. White ◽

J. Shamash ◽

I.M. Hennig ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Randomized Phase Ii ◽

Long Term Follow Up

Download Full-text

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)

European Journal of Cancer ◽

10.1016/j.ejca.2019.12.028 ◽

2020 ◽

Vol 127 ◽

pp. 139-149

Author(s):

Fay H. Cafferty ◽

Jeff D. White ◽

Jonathan Shamash ◽

Ivo Hennig ◽

Sally P. Stenning ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Long Term Outcomes

Download Full-text

Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)

European Urology Supplements ◽

10.1016/s1569-9056(19)32534-5 ◽

2019 ◽

Vol 18 (4) ◽

pp. 28

Author(s):

R.A. Huddart ◽

F. Cafferty ◽

J.D. White ◽

J. Shamash ◽

I. Hennig ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Randomized Phase Ii ◽

Long Term Follow Up

Download Full-text

7142 POSTER Toxicity and Use of Granulocyte Colony-stimulating Factor Prophylaxis in a Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor Prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN53643604)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72057-3 ◽

2011 ◽

Vol 47 ◽

pp. S517

Author(s):

R.A. Huddart ◽

R. Gabe ◽

S.P. Stenning ◽

P. Pollock ◽

J.D. White ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Randomized Phase Ii ◽

Stimulating Factor

Download Full-text

Randomised phase II trial comparing intensive induction chemotherapy (CBOP BEP) with standard BEP chemotherapy in poor prognosis male germ cell tumours

http://isrctn.org/> ◽

10.1186/isrctn53643604 ◽

2013 ◽

Author(s):

Robert Huddart

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Male Germ Cell ◽

Germ Cell Tumours ◽

Bep Chemotherapy

Download Full-text

Dose-dense BEP (ddBEP) regimen as induction chemotherapy (CT) in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumors (NSGCT): Safety results of phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e15540 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e15540-e15540

Author(s):

Alexey Tryakin ◽

Mikhail Fedyanin ◽

Urii Sergeev ◽

Anatoly Bulanov ◽

Bahrom Ahmedov ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumors ◽

Nonseminomatous Germ Cell Tumors

Download Full-text

Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumors (NSGCT): Efficacy results of phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e15566 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e15566-e15566 ◽

Author(s):

Alexey Tryakin ◽

Mikhail Fedyanin ◽

Urii Sergeev ◽

Anatoly Bulanov ◽

Bahrom Ahmedov ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumors ◽

Nonseminomatous Germ Cell Tumors

Download Full-text

A randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor prognosis germ cell tumors (MRC TE23, CRUK 05/014, ISRCTN53643604).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4508 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4508-4508 ◽

Author(s):

R. A. Huddart ◽

R. Gabe ◽

F. Cafferty ◽

P. Pollock ◽

J. D. White ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumors ◽

Randomized Phase Ii

Download Full-text

Paclitaxel plus BEP (T-BEP) regimen as induction chemotherapy (CT) in nonseminomatous germ cell tumors (NSGCT) patients with poor prognosis: A phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4587 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4587-4587

Author(s):

A. Tryakin ◽

M. Fedyanin ◽

U. Sergeev ◽

I. Pokataev ◽

B. Ahmedov ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Study ◽

Germ Cell Tumors ◽

Nonseminomatous Germ Cell Tumors ◽

Patients With Poor Prognosis

Download Full-text

Phase II trial of dose-dense BEP for intermediate- and poor-prognosis metastatic germ cell tumors.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e15011 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15011-e15011 ◽

Author(s):

Y. L. Rimmer ◽

J. D. Chester ◽

D. P. Stark ◽

J. K. Joffe ◽

J. Shamash ◽

...

Keyword(s):

Germ Cell ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumors ◽

Download Full-text